A method of treating or managing non- constipating irritable bowel syndrome (IBS), which comprises administering to a patient suffering from non- constipating IBS an amount of a tryptophan hydroxylase (TPH) inhibitor. Assays and kits useful in the treatment of IBS are also disclosed.